The independent source for health policy research, polling, and news.
Showing 221 - 240 of 585
The Trump administration issued the final rule on association health plans, which supporters say will make coverage more affordable for some employees but led others to warn about “junk insurance.”
The Trump administration is arguing that since Congress is repealing the penalty for not having insurance, the federal health law’s protection for people who have illnesses is unconstitutional.
A provision of this massive legislation would provide funding to help agricultural groups set up association health plans — a longtime GOP-favored mechanism to reduce health insurance costs for small groups.
Self-management classes can help the tens of millions of Americans now diagnosed with Type 2 diabetes. But the education can come with a high price tag.
The federal Centers for Medicare & Medicaid Services advised the state that its plan to offer state-based insurance plans falls short of the Obamacare rules and could result in penalties for insurers.
Incentives to encourage health care consumers to shop around gain momentum as a means to rein in spending.
The policy change is likely to entice younger and healthier people from the general insurance pool by allowing a range of lower-cost options that don’t include all the benefits required by the federal health law.
Focus turns to whether the Trump administration will challenge Idaho’s move to allow such plans to be sold to individuals.
A report issued by the National Academy for State Health Policy shows a small decrease in sign-ups last fall, but states running their own marketplaces did better than those that don’t.
Many eyes are on the Trump administration to see how officials respond to Idaho’s approach to health insurance, which flouts some aspects of the Affordable Care Act.
Proponents say the proposed regulation will give some consumers more affordable insurance options. Critics warn that the coverage could be less comprehensive.
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
The federal marketplace generally uses credit reports to help verify identities, but that doesn’t work if consumers have put a security freeze on them — as some did after the Equifax breach this year. Workarounds for this issue exist, but they make the process more time-consuming.
But buyer, beware. Cobbling together “packages” designed to cover gaps in high-deductible health plans could shortchange consumers, warn advocates.
As stopgap health plans gain attention as possible alternatives to Obamacare, consumers are advised to read the fine print.
Regulators are beginning to scrutinize claims by companies that their alternative plans help people meet Obamacare requirements.
With federal support slashed for organizations that provided consumers help in making their health plan choices, insurance brokers have to pick up the slack.
This year’s Obamacare open enrollment will be marked by a number of changes. KHN helps you navigate them.
A quick guide to revisions to the cost-sharing subsidies for lower-income marketplace customers and the proposal to add different plans to the market.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF